COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction o...

Full description

Saved in:
Bibliographic Details
Main Authors HARRISON, STEPHEN, WARD, SIMON, E, THEWLIS, KEVIN, MICHAEL, HUGHES, OWEN, RHYS, NEESOM, JAMES, KENNETH, CHAN, WAI, NGOR
Format Patent
LanguageEnglish
French
Published 30.04.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed. L'invention concerne des composés de formule (I) et leurs sels, dans laquelle R1, R2, R3, R4 et X sont tels que définis dans la description. L'invention concerne également leurs procédés de préparation, leurs compositions pharmaceutiques et leurs utilisations en tant que médicament, par exemple pour le traitement d'une maladie ou d'un trouble induit par une réduction ou un déséquilibre du fonctionnement du récepteur de glutamate, par exemple la schizophrénie ou une déficience cognitive.
AbstractList The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed. L'invention concerne des composés de formule (I) et leurs sels, dans laquelle R1, R2, R3, R4 et X sont tels que définis dans la description. L'invention concerne également leurs procédés de préparation, leurs compositions pharmaceutiques et leurs utilisations en tant que médicament, par exemple pour le traitement d'une maladie ou d'un trouble induit par une réduction ou un déséquilibre du fonctionnement du récepteur de glutamate, par exemple la schizophrénie ou une déficience cognitive.
Author NEESOM, JAMES, KENNETH
CHAN, WAI, NGOR
WARD, SIMON, E
HARRISON, STEPHEN
HUGHES, OWEN, RHYS
THEWLIS, KEVIN, MICHAEL
Author_xml – fullname: HARRISON, STEPHEN
– fullname: WARD, SIMON, E
– fullname: THEWLIS, KEVIN, MICHAEL
– fullname: HUGHES, OWEN, RHYS
– fullname: NEESOM, JAMES, KENNETH
– fullname: CHAN, WAI, NGOR
BookMark eNqNyrsKwjAUANAMOvj6hwvOQrQt6BiSW5IhD5pbOpYi10nSQv1_XPwAp7OcvdiUufBOoI4-xT6YDIN12kKKhIGcIgTlk4IONSaKHahgoM-YgSx2GFtwATwap13Ao9i-pvfKp58HcW6RtL3wMo-8LtOTC3_GId6kfMimquu7ulb_rS9Tsi6g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSÉS QUI POTENTIALISENT LE RÉCEPTEUR AMPA ET LEURS UTILISATIONS EN MÉDECINE
ExternalDocumentID WO2009053448A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2009053448A13
IEDL.DBID EVB
IngestDate Fri Jul 19 11:58:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2009053448A13
Notes Application Number: WO2008EP64407
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&CC=WO&NR=2009053448A1
ParticipantIDs epo_espacenet_WO2009053448A1
PublicationCentury 2000
PublicationDate 20090430
PublicationDateYYYYMMDD 2009-04-30
PublicationDate_xml – month: 04
  year: 2009
  text: 20090430
  day: 30
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies NEESOM, JAMES, KENNETH
GLAXO GROUP LIMITED
CHAN, WAI, NGOR
WARD, SIMON, E
HARRISON, STEPHEN
HUGHES, OWEN, RHYS
THEWLIS, KEVIN, MICHAEL
RelatedCompanies_xml – name: THEWLIS, KEVIN, MICHAEL
– name: GLAXO GROUP LIMITED
– name: CHAN, WAI, NGOR
– name: HARRISON, STEPHEN
– name: HUGHES, OWEN, RHYS
– name: NEESOM, JAMES, KENNETH
– name: WARD, SIMON, E
Score 2.7341201
Snippet The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&locale=&CC=WO&NR=2009053448A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K3Nt32MKRLU1qhSamd29tobQuCdMNV_Pe9xc3taW8hgeMSuI9fLvcLwGNaZkaZ0o7ep12qo5fs6Jlld3WDllavREhiKPriUNj-2HqZ0mkDPje9MIon9EeRI6JFvaO918pfL7aXWK56W7l8yj5wav7sJUNX26DjwYrCSnNHQx5JVzKNMcRtmoj_1qiJYMRBrHSAiXRvZQ_8bbTqS1nsBhXvFA4jlFfVZ9AoqhYcs83fay04CtclbxyurW95DpzJMJJj4b6SiR8wn0Qy4SIJnIQTJ4wcEnPGo0TGxBEuGaOnJInPYy49EgiiiBwDwS_gweMJ83XUZ_a__dlE7ipvXkKzmlfFFRCaWWVumaaRDnLMg4o-ZnvdvIcJmp2baX9wDe19km72L9_CybZy0oZm_fVd3GEArrN7dW6_dmCBSQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8VubffxMKRLU1pdk1Izt7fRri0I0g1X8d_3Vje3p72FBI5L4D5-udwvAI9RFmtZZDbVrtkyVfSSTTU22i1VMzOjkyEk0Ur6Yp-33ZHxMjEnFfjc9MKUPKE_JTkiWtQM7b0o_fVie4lll28rl0_xB07Nnx3Zt5UNOu6tKKwUe9BngbAFVShF3Kbw8G_N1BGMWIiVDjDJ7qzsgb0PVn0pi92g4pzAYYDy8uIUKmlehxrd_L1WhyN_XfLG4dr6lmfAqPADMeL2Gxm7HnVJICTj0rMkI5YfWCRklAVShMTiNhmhpyTSZSETDvE4KYkcPc7O4cFhkroq6jP93_50LHaV1y-gms_z9BKIGRtZYui6FvUSzIPSLmZ7raSDCVo70aNu7woa-yRd71--h5or_eF06PHXGzjeVlEaUC2-vtNbDMZFfFee4S-ylIQ8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+WHICH+POTENTIATE+AMPA+RECEPTOR+AND+USES+THEREOF+IN+MEDICINE&rft.inventor=HARRISON%2C+STEPHEN&rft.inventor=WARD%2C+SIMON%2C+E&rft.inventor=THEWLIS%2C+KEVIN%2C+MICHAEL&rft.inventor=HUGHES%2C+OWEN%2C+RHYS&rft.inventor=NEESOM%2C+JAMES%2C+KENNETH&rft.inventor=CHAN%2C+WAI%2C+NGOR&rft.date=2009-04-30&rft.externalDBID=A1&rft.externalDocID=WO2009053448A1